Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Delayed Quote USD

InfuSystem Holdings, Inc. (INFU)

4.8500
+0.1000
+(2.11%)
At close: May 2 at 4:00:00 PM EDT
4.8500
+0.03
+(0.62%)
After hours: May 2 at 4:05:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
134,861
134,861
125,785
109,914
102,382
Cost of Revenue
64,458
64,458
62,676
49,354
43,846
Gross Profit
70,403
70,403
63,109
60,560
58,536
Operating Expense
63,512
63,512
59,021
58,906
55,716
Operating Income
6,891
6,891
4,088
1,654
2,820
Net Non Operating Interest Income Expense
-1,777
-1,777
-2,170
-1,402
-1,377
Other Income Expense
-55
-55
-67
-122
-186
Pretax Income
5,059
5,059
1,851
130
1,257
Tax Provision
2,714
2,714
979
112
-163
Net Income Common Stockholders
2,345
2,345
872
18
1,420
Diluted NI Available to Com Stockholders
2,345
2,345
872
18
1,420
Basic EPS
0.07
0.11
0.04
0.00
0.07
Diluted EPS
0.07
0.11
0.04
0.00
0.06
Basic Average Shares
21,251.7420
21,271.6080
21,024.3820
20,648.8180
20,519.9580
Diluted Average Shares
21,715.1760
21,707.1510
21,646.0790
21,547.3060
22,049.6590
Total Operating Income as Reported
6,891
6,891
4,088
1,654
2,820
Total Expenses
127,970
127,970
121,697
108,260
99,562
Net Income from Continuing & Discontinued Operation
2,345
2,345
872
18
1,420
Normalized Income
2,345
2,345
872
18
1,420
Interest Expense
1,777
1,777
2,170
1,402
1,377
Net Interest Income
-1,777
-1,777
-2,170
-1,402
-1,377
EBIT
6,836
6,836
4,021
1,532
2,634
EBITDA
19,335
19,335
16,529
14,892
17,259
Reconciled Cost of Revenue
52,950
52,950
51,158
38,488
33,483
Reconciled Depreciation
12,499
12,499
12,508
13,360
14,625
Net Income from Continuing Operation Net Minority Interest
2,345
2,345
872
18
1,420
Normalized EBITDA
19,335
19,335
16,529
14,892
17,259
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 12/27/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DXR Daxor Corporation
7.53
-2.71%
 
SMTI Sanara MedTech Inc.
32.89
+2.02%
 
NXGL NEXGEL, Inc.
2.6600
+1.53%
 
KRMD KORU Medical Systems, Inc.
2.8500
+3.64%
 
BLFS BioLife Solutions, Inc.
25.27
+2.72%
 
ANGO AngioDynamics, Inc.
9.29
+1.09%
 
GXI.DE Gerresheimer AG
60.55
+1.94%
 
LMAT LeMaitre Vascular, Inc.
78.70
-12.79%
 
RGEN Repligen Corporation
141.51
+3.14%
 
HOLX Hologic, Inc.
54.16
-5.45%